Related Experiment Video
Updated: Aug 12, 2026

23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Response to anticoagulant drug withdrawal
Journal of the American Dental Association (1939)
|September 1, 1987
Summary
For dental procedures, a 2-day anticoagulant medication withdrawal is effective and safe. This approach prevented thromboembolic and hemorrhagic events in patients undergoing dental work.
Area of Science:
- Cardiology
- Dental Surgery
- Pharmacology
Background:
- Anticoagulant medications are crucial for preventing thromboembolic events.
- Managing anticoagulation requires careful consideration during invasive procedures like dental surgery.
- Medication withdrawal protocols need to balance bleeding risk with thrombotic risk.
Purpose of the Study:
- To evaluate the safety and efficacy of a 2-day anticoagulant medication withdrawal period for dental procedures.
- To assess the incidence of thromboembolic and hemorrhagic events following dental treatment after medication withdrawal and reinstitution.
Main Methods:
- The study involved 17 subjects at a hospital anticoagulation clinic.
- 44 separate medication withdrawal periods were evaluated in relation to dental procedures.
- Monitoring for thromboembolic and hemorrhagic events occurred post-procedure and after medication reinstitution.
Main Results:
- A 2-day anticoagulant medication withdrawal period was found to be effective for dental procedures.
- No thromboembolic events were observed during the study.
- No posttreatment hemorrhagic episodes occurred after reinstituting anticoagulant medication.
Conclusions:
- A 2-day anticoagulant hold is a safe and effective strategy for patients requiring dental procedures.
- Close monitoring of prothrombin time is essential due to potential fluctuations, even in well-managed patients.
Related Concept Videos
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

